Medscape has launched the latest educational activity in their “Clinical Advances in Gene Therapy for Hemophilia” series, which is presented through a collaboration between Medscape, the National Hemophilia Foundation, the European Haemophilia Consortium and the World Federation of Hemophilia. The program is supported by an independent educational grant from BioMarin.
The goal of “Gene Therapy: Past, Present, and Future” is to discuss the evolution of gene therapy, including its development, ongoing research, and current and future uses, as well as how it may impact hemophilia in the future.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- History of gene therapy
- Different approaches being investigated for gene therapies
Gene Therapy: Past, Present, and Future
Authors: Steven W. Pipe, MD; David Lillicrap, MD; Ulrike M. Reiss, MD
CME / ABIM MOC Released: 6/25/2018
Valid for credit through: 6/25/2019
If you are already registered with Medscape follow this link to “Gene Therapy: Past, Present, and Future.”
Access this link to visit the “Clinical Advances in Gene Therapy for Hemophilia” homepage.
If you are not already registered, simply go to Medscape.org where registration is straightforward and free of charge.
